+86-571-8627 3270
Chongqing Beisheng Pharmaceutical Co.,Ltd.
15 YRS
Chongqing City, China
CNY 132 Million
100-500 people
Main Products: Paclitaxel / Docetaxel / Cabazitaxel / Palbociclib / Ribociclib / Venetoclax / Capecitabine / Ibrutinib / Lcz696 / Abemaciclib / Alectinib / Neratinib / Roxadustat / Rucaparib Phosphate / Rucaparib Camsylate / (R,E)-5-([1,1'-Biphenyl]-4-yl)-4-((tert-Butoxycarbonyl)Amino)-2-Methylpent-2-Enoic acid / 5-Fluoro-2-Methylbenzoic Acid / 6-Fluoro-1H-Indole-4-Carboxylic acid Methyl Ester / (S)-2-Aminobutyramide Hydrochloride / L-2-Aminobutyric acid / tert-Butyl 4-(6-Aminopyridin-3-yl)Piperazine-1-Carboxylate / 6-Bromo-2-Chloro-8-Cyclopentyl-5-Methylpyrido[2,3-D]Pyrimidin-7(8H)-One / (2R,4S)-5-([1,1'-Biphenyl]-4-Yl)-4-((Tert-Butoxycarbonyl)Amino)-2-Methylpentanoic Acid / Lcz696 Intemediate
Chongqing City, China
ABOUT US
Chongqing Beisheng Pharmaceutical Technology Co., Ltd. is a high-tech enterprise specializing in the development of new drugs, drug intermediates, chemical process development and large-scale production. It is mainly committed to the research, development and production of pharmaceutical raw materials and organic intermediates with high technical barriers, great difficulty and high added value. At present, the company has built a 3500 square meter R&D center in the water and soil high tech park of Liangjiang New Area, Chongqing, equipped with about 410 first-class experimental equipment and analytical instruments, and has more than 80 high-quality R&D personnel, of which 70% have master's degree or above. With rich product development experience, the company can win a series of R & D tasks such as organic synthesis, biological fermentation and natural product extraction. The production base is located in Sansheng Town, Beibei District, Chongqing. At present, multi-functional chemical synthesis workshop, biological fermentation workshop and natural product extraction and purification workshop have been built, with about 320 sets of production equipment, and synthesis, fermentation and preparation production lines are under construction. At the same time, there is nearly 10000 mu of yew and other high value-added medicinal materials planting base at the south foot of Huaying Mountain - Qingfeng mountain, with an altitude of 800-1040m. The climate, soil and other conditions are suitable for the growth of yew mandia. The company carries out artificial cultivation of Taxus mandia in strict accordance with gap specifications, with an annual seedling raising capacity of more than 10 million, and has become one of the largest cultivation and planting parks of Taxus mandia in China. Adhering to the tenet of "being grateful to nature, returning to society, serving customers and inheriting health", the company has established an innovative pharmaceutical enterprise integrating R & D, production and sales, and is willing to become an excellent pharmaceutical enterprise at home and abroad in terms of new product development, process improvement and optimization Reliable strategic partner for high-end customization.
Basic Information
Tax ID
915000006912071730
Country/Region
Chongqing City, China
Year Established
2009
Registered Capital
CNY 132 Million
Business Type
Manufacturing
Total Employees
100-500 people
Quality Management Certificate
SFDA-GMP
Total Annual Revenue
-
Enterprise Ownership
Private Owned
Is This Your Own Factory
Yes
Summary Up
The company relies on Taxus chinensis, takes natural plant extraction as the basis, and takes anti-tumor, cardiovascular drugs and Taxus chinensis series products as the core
PLANT LOCATION
ORGANIZATION UNIT
80 People
R&D Dept
COMPANY ALBUM
办公区域
办公区域
办公区域
办公区域
生产车间
生产车间
公司参展
公司活动
公司活动
其他图片
CERTIFICATES
Sign In
Please enter your email address correctly
Please enter your password
Forgot Password
OR
Join Free >